NCT02794038

Brief Summary

This study scope is to validate the accuracy and usability of the Soberlink Cellular Device in comparison to a predicate device, BACtrack S80 Pro.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2016

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 31, 2016

Completed
1 day until next milestone

Study Start

First participant enrolled

June 1, 2016

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 8, 2016

Completed
Last Updated

June 10, 2016

Status Verified

June 1, 2016

Enrollment Period

Same day

First QC Date

May 31, 2016

Last Update Submit

June 9, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Validate the accuracy of the Soberlink Cellular Device in comparison to a predicate device, BACtrack S80 Pro and assessed by linear regression.

    Performance validation will occur by evaluating the accuracy of the Soberlink Cellular device in the hand of intended users - untrained study participants who have consumed alcohol and use the device to measure their blood alcohol content (BAC). 40 adults will be recruited who have recently consumed alcohol. The only assistance to be provided is the labeling. No additional coaching, either written or verbal, will be provided to study participants. Participants should obtain a BAC reading with the Soberlink Cellular device, and a second BAC reading with a comparator device. The second measurement will be taken within 5 minutes of the first. A linear regression line for the comparison between results of the Soberlink Cellular device and a comparator will be made.

    Day 1

Secondary Outcomes (1)

  • Validate the usability of the Soberlink Cellular Device in comparison to a predicate device, BACtrack S80 Pro and assessed by Questionnaire.

    Day 1

Study Arms (2)

Soberlink Cellular Device

ACTIVE COMPARATOR

BAC reading with Soberlink Cellular Device

Device: BACtrack S80 Pro

BACtrack S80 Pro

ACTIVE COMPARATOR

BAC reading with BACtrack S80 Pro

Device: Soberlink Cellular Device

Interventions

BAC breath analyzer

BACtrack S80 Pro

BAC breath analyzer

Soberlink Cellular Device

Eligibility Criteria

Age21 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject willing to sign an informed consent
  • Male or female subject between the ages of 21-99 years old
  • Untrained subject in the use of an Alcohol Breathalyzer
  • Subject willing to consume two alcoholic drinks
  • Subjects willing to use two Alcohol Breathalyzers
  • Subject willing to complete a Questionnaire

You may not qualify if:

  • Subject with previous Alcohol Breathalyzer experience
  • Subject currently in substance use rehabilitation or post rehabilitation, or unauthorized to consume alcohol for any other reason
  • Subject with lung disease, or is physically unable to provide a deep lung exhalation for 4 seconds
  • Subject unwilling to drink two alcoholic drinks
  • Subject unwilling to complete a questionnaire
  • Subject that is non-English speaking
  • Subject that is a child, adolescent, or cognitively impaired.
  • Subject that is a pregnant and/or breastfeeding woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Substance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Study Officials

  • Shannon Hanrahan, PhD

    Private Practice

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 31, 2016

First Posted

June 8, 2016

Study Start

June 1, 2016

Primary Completion

June 1, 2016

Study Completion

June 1, 2016

Last Updated

June 10, 2016

Record last verified: 2016-06

Data Sharing

IPD Sharing
Will share

Participant will be aware of their own BAC result as the result is displayed on the LED screen of the device